The significance of secukinumab in the treatment of plaque psoriasis
Psoriasis is a chronic inflammatory skin disease that affects approximately 1–3% of the general population in Poland. It is estimated that in 70–80% of patients skin lesions are mild and require only topical medications. In severe plaque psoriasis, classic treatments often lead to a loss of efficacy...
Main Authors: | Marta Kasprowicz-Furmańczyk, Agnieszka Owczarczyk-Saczonek |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2022-02-01
|
Series: | Przegląd Dermatologiczny |
Subjects: | |
Online Access: | https://www.termedia.pl/The-significance-of-secukinumab-in-the-treatment-of-plaque-psoriasis,56,46319,1,1.html |
Similar Items
-
Secukinumab for plaque psoriasis
by: Gonzalo Ordenes-Cavieres, et al.
Published: (2018-11-01) -
Treatment challenges in the management of moderate-to-severe plaque psoriasis – role of secukinumab
by: Malakouti M, et al.
Published: (2016-10-01) -
Secukinumab in psoriasis: A single-center experience
by: Esra Ağaoğlu, et al.
Published: (2021-09-01) -
Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
by: Alessio Gambardella
Published: (2019-09-01) -
Personalized Secukinumab Treatment in Patients with Plaque Psoriasis Using Model-Informed Precision Dosing
by: Karine Rodriguez-Fernandez, et al.
Published: (2024-12-01)